Abstract

Francisella tularensis is a facultative intracellular bacterium and the causative agent of tularemia. Development of novel vaccines and therapeutics for tularemia has been hampered by the lack of understanding of which immune components are required to survive infection. Defining these requirements for protection against virulent F. tularensis, such as strain SchuS4, has been difficult since experimentally infected animals typically die within 5 days after exposure to as few as 10 bacteria. Such a short mean time to death typically precludes development, and therefore assessment, of immune responses directed against virulent F. tularensis. To enable identification of the components of the immune system that are required for survival of virulent F. tularensis, we developed a convalescent model of tularemia in C57Bl/6 mice using low dose antibiotic therapy in which the host immune response is ultimately responsible for clearance of the bacterium. Using this model we demonstrate αβTCR+ cells, γδTCR+ cells, and B cells are necessary to survive primary SchuS4 infection. Analysis of mice deficient in specific soluble mediators shows that IL-12p40 and IL-12p35 are essential for survival of SchuS4 infection. We also show that IFN-γ is required for survival of SchuS4 infection since mice lacking IFN-γR succumb to disease during the course of antibiotic therapy. Finally, we found that both CD4+ and CD8+ cells are the primary producers of IFN-γand that γδTCR+ cells and NK cells make a minimal contribution toward production of this cytokine throughout infection. Together these data provide a novel model that identifies key cells and cytokines required for survival or exacerbation of infection with virulent F. tularensis and provides evidence that this model will be a useful tool for better understanding the dynamics of tularemia infection.

Highlights

  • Francisella tularensis is a Gram negative, facultative intracellular pathogen

  • Since the majority of mice with targeted deletions in genes participating in immune responses are on a C57Bl/6 background, we first tested a dose of 40 mg/kg of LVF for its ability to enhance survival of intranasal SchuS4 infection in C57Bl/6 mice

  • We utilized antibiotic therapy to extend the course of infection with virulent F. tularensis ssp. tularensis strain SchuS4 in order to identify components of the immune response that are required for survival of primary infection with SchuS4

Read more

Summary

Introduction

Francisella tularensis is a Gram negative, facultative intracellular pathogen. Currently, there are five major subspecies of F. tularensis. Subspecies novicida is relatively non-pathogenic to humans [2]. It has been employed by many laboratories as a model intracellular pathogen that resides in the cytosol of host cells. Subspecies holarctica can cause disease in humans, but is rarely fatal. This subspecies readily infects and causes lethal disease in mice [3,4]. Further attenuation of subspecies holarctica resulted in generation of the Live Vaccine Strain (LVS) [5]. Similar to F. novicida, these phenomena make LVS infection in mice an interesting model for requirements of immunity against intracellular pathogens

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call